Cargando…

Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.

A simple method for the rapid expansion of human CD4+ T cells with both helper and killer functions was established. CD4+ T cells separated from peripheral blood mononuclear cells using immunomagnetic beads were stimulated with immobilised OKT-3 monoclonal antibody (mAb) plus recombinant interleukin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Y., Tokuda, Y., Iwasawa, M., Tsukamoto, H., Kidokoro, M., Kobayashi, N., Kato, S., Mitomi, T., Habu, S., Nishimura, T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1992
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977880/
https://www.ncbi.nlm.nih.gov/pubmed/1353365
_version_ 1782135357004840960
author Nakamura, Y.
Tokuda, Y.
Iwasawa, M.
Tsukamoto, H.
Kidokoro, M.
Kobayashi, N.
Kato, S.
Mitomi, T.
Habu, S.
Nishimura, T.
author_facet Nakamura, Y.
Tokuda, Y.
Iwasawa, M.
Tsukamoto, H.
Kidokoro, M.
Kobayashi, N.
Kato, S.
Mitomi, T.
Habu, S.
Nishimura, T.
author_sort Nakamura, Y.
collection PubMed
description A simple method for the rapid expansion of human CD4+ T cells with both helper and killer functions was established. CD4+ T cells separated from peripheral blood mononuclear cells using immunomagnetic beads were stimulated with immobilised OKT-3 monoclonal antibody (mAb) plus recombinant interleukin 2 (rIL-2) in 96 well culture plates. After 6 day-culture, the CD4+ T cells were restimulated by immobilised OKT-3 mAb for an additional 24 h, then inoculated into concentrated rotary-tissue culture bag and cultured for further 9 days. This procedure yielded a 3000-fold increase in cell number (about 3-5 x 10(9) per bag). Most of the cells (over 96%) continued to express CD4+ antigen and retained their capacity to produce IL-2. The activated CD4+ T cells showed marked cytotoxicity against Fc receptor positive tumour cells in the presence of OKT-3 mAb. Moreover, we succeeded in a specific targeting of the expanded CD4+ helper/killer T cells to c-erb B-2 positive tumour cells by means of anti-CD3 x anti-c-erb B-2 bispecific antibody. These results suggested that our established simple system will be available for the expansion of large number of CD4+ helper/killer T cells which may provide an efficient strategy for adoptive tumour immunotherapy.
format Text
id pubmed-1977880
institution National Center for Biotechnology Information
language English
publishDate 1992
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-19778802009-09-10 Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy. Nakamura, Y. Tokuda, Y. Iwasawa, M. Tsukamoto, H. Kidokoro, M. Kobayashi, N. Kato, S. Mitomi, T. Habu, S. Nishimura, T. Br J Cancer Research Article A simple method for the rapid expansion of human CD4+ T cells with both helper and killer functions was established. CD4+ T cells separated from peripheral blood mononuclear cells using immunomagnetic beads were stimulated with immobilised OKT-3 monoclonal antibody (mAb) plus recombinant interleukin 2 (rIL-2) in 96 well culture plates. After 6 day-culture, the CD4+ T cells were restimulated by immobilised OKT-3 mAb for an additional 24 h, then inoculated into concentrated rotary-tissue culture bag and cultured for further 9 days. This procedure yielded a 3000-fold increase in cell number (about 3-5 x 10(9) per bag). Most of the cells (over 96%) continued to express CD4+ antigen and retained their capacity to produce IL-2. The activated CD4+ T cells showed marked cytotoxicity against Fc receptor positive tumour cells in the presence of OKT-3 mAb. Moreover, we succeeded in a specific targeting of the expanded CD4+ helper/killer T cells to c-erb B-2 positive tumour cells by means of anti-CD3 x anti-c-erb B-2 bispecific antibody. These results suggested that our established simple system will be available for the expansion of large number of CD4+ helper/killer T cells which may provide an efficient strategy for adoptive tumour immunotherapy. Nature Publishing Group 1992-07 /pmc/articles/PMC1977880/ /pubmed/1353365 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Nakamura, Y.
Tokuda, Y.
Iwasawa, M.
Tsukamoto, H.
Kidokoro, M.
Kobayashi, N.
Kato, S.
Mitomi, T.
Habu, S.
Nishimura, T.
Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.
title Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.
title_full Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.
title_fullStr Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.
title_full_unstemmed Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.
title_short Large-scale culture system of human CD4+ helper/killer T cells for the application to adoptive tumour immunotherapy.
title_sort large-scale culture system of human cd4+ helper/killer t cells for the application to adoptive tumour immunotherapy.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977880/
https://www.ncbi.nlm.nih.gov/pubmed/1353365
work_keys_str_mv AT nakamuray largescaleculturesystemofhumancd4helperkillertcellsfortheapplicationtoadoptivetumourimmunotherapy
AT tokuday largescaleculturesystemofhumancd4helperkillertcellsfortheapplicationtoadoptivetumourimmunotherapy
AT iwasawam largescaleculturesystemofhumancd4helperkillertcellsfortheapplicationtoadoptivetumourimmunotherapy
AT tsukamotoh largescaleculturesystemofhumancd4helperkillertcellsfortheapplicationtoadoptivetumourimmunotherapy
AT kidokorom largescaleculturesystemofhumancd4helperkillertcellsfortheapplicationtoadoptivetumourimmunotherapy
AT kobayashin largescaleculturesystemofhumancd4helperkillertcellsfortheapplicationtoadoptivetumourimmunotherapy
AT katos largescaleculturesystemofhumancd4helperkillertcellsfortheapplicationtoadoptivetumourimmunotherapy
AT mitomit largescaleculturesystemofhumancd4helperkillertcellsfortheapplicationtoadoptivetumourimmunotherapy
AT habus largescaleculturesystemofhumancd4helperkillertcellsfortheapplicationtoadoptivetumourimmunotherapy
AT nishimurat largescaleculturesystemofhumancd4helperkillertcellsfortheapplicationtoadoptivetumourimmunotherapy